Skip to main content
. 2022 Mar 8;55(3):542–556.e5. doi: 10.1016/j.immuni.2022.01.017

Figure 2.

Figure 2

Immune cell profile is altered in post-COVID-19 BAL over 80 days after discharge

(A) Left: total number of cells in BAL from healthy controls and post COVID-19 patients. Right: total number of cells in BAL from post-COVID-19 patients, stratified according to severity of the acute illness.

(B) Total cell numbers of immune populations (×106/mL) in BAL from healthy controls and post-COVID-19 patients, based on gating shown in STAR Methods and Figure 1.

(A and B) Data are presented as mean ± SEM. Healthy controls, n = 16; post-COVID-19 patients, n = 28, moderate n = 9, severe n = 11, very severe n = 8. Statistical significance was tested by Mann-Whitney U test or one-way ANOVA + Tukey’s multiple comparison test. p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005. See also Figure S1.